Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
28,072,332
-
Shares change
-
+787,800
-
Total reported value, excl. options
-
$242,731,438
-
Value change
-
+$10,955,423
-
Number of buys
-
37
-
Number of sells
-
-28
-
Price
-
$8.64
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2021
83 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q3 2021.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,072,332 shares
.
Largest 10 shareholders include Bellevue Group AG (4,533,148 shares), Logos Global Management LP (4,100,000 shares), BlackRock Inc. (2,631,816 shares), FRANKLIN RESOURCES INC (2,278,349 shares), VANGUARD GROUP INC (1,916,849 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1,409,956 shares), MORGAN STANLEY (1,216,756 shares), ORBIMED ADVISORS LLC (1,150,000 shares), DEUTSCHE BANK AG\ (791,536 shares), and Palo Alto Investors LP (656,200 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.